Current Duke Appointments & Affiliations
Associate Professor of Medicine
·
2021 - Present
Medicine, Medical Oncology,
Medicine
Member of the Duke Cancer Institute
·
2021 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Scholarly Works
Patterns of Poly(ADP-ribose) Polymerase Inhibitor Use and Overall Survival in United States Veterans with Prostate Cancer
Journal article Clinical Genitourinary Cancer · August 2026 Full text CiteSPOP Mutations in Veterans With Prostate Cancer and Outcomes With Doublet and Triplet Therapy in De Novo Metastatic Hormone Sensitive Prostate Cancer.
Journal article Prostate · June 2026 BACKGROUND: Inactivating missense mutations in the tumor suppressor gene speckle-type pox virus and zinc finger protein (SPOP) occur in 5%-15% of men with prostate cancer (PC). SPOP mutations increase androgen receptor-mediated transcription and enhance se ... Full text Link to item CitePatterns of poly(ADP-ribose) polymerase inhibitor use and overall survival in United States veterans with prostate cancer.
Conference Journal of Clinical Oncology · June 1, 2026 e17049Background: PARP inhibitors (PARPi) are life-prolonging therapies for men with ... Full text CiteRecent Grants
Prostate Cancer Research Program Clinical Consortium Award
ResearchCollaborator · Awarded by Department of Defense · 2026 - 2030DoD: PCRP Clinical Consortium: Duke University Clinical Research Site
ResearchCollaborating Investigator · Awarded by Department of Defense · 2007 - 2026PARPi Response Evaluation for Clinical Impact and Scientific Innovation in Oncology: The PRECISION Registry
ResearchCo Investigator · Awarded by Thomas Jefferson University · 2022 - 2022View All Grants
Education
Vanderbilt University ·
2005
M.D.